| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 4.23e-06 | 4 | 205 | 3 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 4.23e-06 | 4 | 205 | 3 | GO:0050119 | |
| GeneOntologyMolecularFunction | deaminase binding | 4.23e-06 | 4 | 205 | 3 | GO:1990827 | |
| GeneOntologyMolecularFunction | heparan sulfate N-deacetylase activity | 3.13e-04 | 3 | 205 | 2 | GO:0102140 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 4.43e-04 | 15 | 205 | 3 | GO:1990247 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 4.43e-04 | 15 | 205 | 3 | GO:0034483 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA modification | 1.71e-05 | 6 | 198 | 3 | GO:0090367 | |
| GeneOntologyBiologicalProcess | regulation of mRNA modification | 2.96e-05 | 7 | 198 | 3 | GO:0090365 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 MCAM NCAM2 GFUS FAT2 NRXN1 PKD1 FGB PKP2 ASTN2 PCDHB1 DPP4 FAT4 RAP2B PCDHGB5 WNT5A FAT3 SHB CLDN7 CLSTN1 IGDCC4 ARID2 PRKCD CTNNA1 CTNND2 | 4.00e-05 | 1077 | 198 | 25 | GO:0098609 |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 4.71e-05 | 8 | 198 | 3 | GO:0015014 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 1.82e-05 | 6 | 205 | 3 | GO:1990826 | |
| GeneOntologyCellularComponent | TRC complex | 9.57e-05 | 2 | 205 | 2 | GO:0072380 | |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 AQP7P3 FAT2 NRXN1 SCN5A PKP2 DPP4 RAP2B CLDN7 KRIT1 PDLIM4 LMO7 PRKCD CTNNA1 CTNND2 RAP2C | 2.52e-04 | 591 | 205 | 16 | GO:0005911 |
| Domain | Heparan_SO4_deacetylase | 4.66e-06 | 4 | 198 | 3 | IPR021930 | |
| Domain | HSNSD | 4.66e-06 | 4 | 198 | 3 | PF12062 | |
| Domain | hnRNP_C | 2.29e-05 | 6 | 198 | 3 | IPR017347 | |
| Domain | - | 6.80e-05 | 95 | 198 | 7 | 2.60.120.200 | |
| Domain | SGTA_dimer | 1.12e-04 | 2 | 198 | 2 | IPR032374 | |
| Domain | SGTA_dimer | 1.12e-04 | 2 | 198 | 2 | PF16546 | |
| Domain | ConA-like_dom | RYR1 FAT2 NRXN1 SEL1L3 RANBP10 FAT4 COL12A1 FAT3 CLSTN1 PAPPA | 1.19e-04 | 219 | 198 | 10 | IPR013320 |
| Domain | CADHERIN_1 | 2.03e-04 | 113 | 198 | 7 | PS00232 | |
| Domain | Cadherin | 2.03e-04 | 113 | 198 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 2.14e-04 | 114 | 198 | 7 | PS50268 | |
| Domain | - | 2.14e-04 | 114 | 198 | 7 | 2.60.40.60 | |
| Domain | CA | 2.26e-04 | 115 | 198 | 7 | SM00112 | |
| Domain | Cadherin-like | 2.38e-04 | 116 | 198 | 7 | IPR015919 | |
| Domain | TPR_8 | 2.42e-04 | 53 | 198 | 5 | PF13181 | |
| Domain | Cadherin | 2.65e-04 | 118 | 198 | 7 | IPR002126 | |
| Domain | Laminin_G | 3.70e-04 | 58 | 198 | 5 | IPR001791 | |
| Domain | - | ZGRF1 NDST4 DNAH14 NDST3 ABCG4 ABCC1 NDST1 RAP2A RAP2B DDX60 INO80 RFC2 RAB20 SBNO2 ATAD3A DHX32 AGAP9 RAP2C TDRD12 | 3.82e-04 | 746 | 198 | 19 | 3.40.50.300 |
| Domain | TPR_1 | 3.91e-04 | 90 | 198 | 6 | IPR001440 | |
| Domain | TPR_1 | 3.91e-04 | 90 | 198 | 6 | PF00515 | |
| Domain | LAM_G_DOMAIN | 6.82e-04 | 38 | 198 | 4 | PS50025 | |
| Pubmed | DCHS2 DNAJA2 NCAM2 FMNL2 GTF3C4 MICU1 SCG2 MIB1 PKD1 ASTN2 ALAD CARS2 PLP1 NDST1 OGT HDAC6 SGTB COPA TTC28 PPFIBP1 SYNE1 SGTA MED13L KRIT1 LMO7 CTNNA1 CTNND2 ZBTB11 GEN1 SLX4 | 2.01e-10 | 1285 | 208 | 30 | 35914814 | |
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 16059920 | ||
| Pubmed | Mutagenesis analysis of human SM22: characterization of actin binding. | 2.11e-07 | 3 | 208 | 3 | 11053353 | |
| Pubmed | HNRNPCL1 KDM3B HNRNPCL3 SLC25A32 AP1B1 HNRNPCL4 C4A C4B WDR48 OGT TTC28 RBL1 PPFIBP1 CLSTN1 SBNO2 HSD17B12 ZBTB11 | 4.54e-07 | 650 | 208 | 17 | 38777146 | |
| Pubmed | Rap2, but not Rap1 GTPase is expressed in human red blood cells and is involved in vesiculation. | 8.40e-07 | 4 | 208 | 3 | 16540189 | |
| Pubmed | hnRNPC induces isoform shifts in miR-21-5p leading to cancer development. | 8.40e-07 | 4 | 208 | 3 | 35729324 | |
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 36681355 | ||
| Pubmed | hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. | 8.40e-07 | 4 | 208 | 3 | 10805751 | |
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 22049073 | ||
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 23831410 | ||
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 12070138 | ||
| Pubmed | Recurrent CNVs disrupt three candidate genes in schizophrenia patients. | 8.40e-07 | 4 | 208 | 3 | 18940311 | |
| Pubmed | KDM3B HEPH NRXN1 SRGAP3 WDR48 TTC28 PPFIBP1 SYNE1 MED13L LMO7 | 1.16e-06 | 225 | 208 | 10 | 12168954 | |
| Pubmed | ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. | 1.20e-06 | 57 | 208 | 6 | 23788249 | |
| Pubmed | HNRNPCL1 DNAJA2 ACTA1 NCAM2 FMNL2 HNRNPCL3 NF1 AP1B1 SRGAP3 C4A C4B PRKAG2 PLP1 HNRNPCL2 RAP2B OGT COPA SYNE1 CARMIL1 NCKIPSD LMO7 ATAD3A CTNNA1 CTNND2 TNS1 | 1.73e-06 | 1431 | 208 | 25 | 37142655 | |
| Pubmed | Ubiquitylation by Rab40b/Cul5 regulates Rap2 localization and activity during cell migration. | 2.09e-06 | 5 | 208 | 3 | 35293963 | |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 29846695 | ||
| Pubmed | Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism. | 2.09e-06 | 5 | 208 | 3 | 25809670 | |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 9128719 | ||
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 11087757 | ||
| Pubmed | Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development. | 3.56e-06 | 18 | 208 | 4 | 33108146 | |
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 26048669 | ||
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 15687492 | ||
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 18363099 | ||
| Pubmed | Selective disruption of genes expressed in totipotent embryonal stem cells. | 4.16e-06 | 6 | 208 | 3 | 1317320 | |
| Pubmed | CENPC DNAJA2 PICALM GTF3C4 MICU1 MIB1 FGB WDR48 COL12A1 HDAC6 PPFIBP1 NCKIPSD TRMT6 AKAP9 JRK BUB3 | 4.58e-06 | 689 | 208 | 16 | 36543142 | |
| Pubmed | 7.25e-06 | 7 | 208 | 3 | 25846207 | ||
| Pubmed | FGF signaling sustains the odontogenic fate of dental mesenchyme by suppressing β-catenin signaling. | 1.15e-05 | 8 | 208 | 3 | 24067353 | |
| Pubmed | Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells. | 1.68e-05 | 26 | 208 | 4 | 15890332 | |
| Pubmed | 1.72e-05 | 9 | 208 | 3 | 10452948 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 1.79e-05 | 135 | 208 | 7 | 31077711 | |
| Pubmed | Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. | 3.36e-05 | 11 | 208 | 3 | 15944372 | |
| Pubmed | KDM3B RYR1 FER1L6 NF1 TMTC3 AP1B1 MIB1 FAT4 MXRA5 TTC28 MUC16 IFIT1 ARID2 CTNND2 | 3.40e-05 | 638 | 208 | 14 | 31182584 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 19062096 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 21911383 | ||
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 3.56e-05 | 2 | 208 | 2 | 17645767 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 3.56e-05 | 2 | 208 | 2 | 27758680 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 35203285 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 3.56e-05 | 2 | 208 | 2 | 3037333 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 11726230 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 4216347 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 3.56e-05 | 2 | 208 | 2 | 8428773 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 24638111 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 28887310 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 3.56e-05 | 2 | 208 | 2 | 21345967 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 2302180 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 37856423 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 22151770 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 29080553 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 27565656 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 3.56e-05 | 2 | 208 | 2 | 25339671 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 17728371 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 6149580 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 6149581 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 3542363 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 2387317 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 7365238 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 17971360 | ||
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 3.56e-05 | 2 | 208 | 2 | 17971229 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 35898513 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 28873507 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 32239963 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 3794341 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 22785613 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 3.56e-05 | 2 | 208 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 3.56e-05 | 2 | 208 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 3.56e-05 | 2 | 208 | 2 | 7373044 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 3.56e-05 | 2 | 208 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 3.56e-05 | 2 | 208 | 2 | 16098595 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 3.56e-05 | 2 | 208 | 2 | 15787745 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 30026462 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 6559257 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 12480675 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 26800705 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 19492056 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 3.56e-05 | 2 | 208 | 2 | 1699796 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 3.56e-05 | 2 | 208 | 2 | 2997024 | |
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 3.56e-05 | 2 | 208 | 2 | 3624865 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 30041577 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 3.56e-05 | 2 | 208 | 2 | 3862104 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 28327544 | ||
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 3.56e-05 | 2 | 208 | 2 | 26814963 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 8132550 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 2395880 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 26814708 | ||
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 3.56e-05 | 2 | 208 | 2 | 1438267 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 19150565 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 17506029 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 23715124 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 2993295 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 12878599 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 33353966 | ||
| Pubmed | Heterogeneity and linkage of equine C4 and steroid 21-hydroxylase genes. | 3.56e-05 | 2 | 208 | 2 | 2900855 | |
| Pubmed | Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis. | 3.56e-05 | 2 | 208 | 2 | 31990681 | |
| Pubmed | Genetic deficiency in complement component 4b does not alter radiation-induced lung disease in mice. | 3.56e-05 | 2 | 208 | 2 | 23259761 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 3.56e-05 | 2 | 208 | 2 | 16565498 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 15998580 | ||
| Cytoband | 2q35-q36 | 1.22e-04 | 4 | 208 | 2 | 2q35-q36 | |
| GeneFamily | Cadherin related | 1.54e-07 | 17 | 141 | 5 | 24 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.83e-04 | 115 | 141 | 6 | 769 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#3_top-relative-expression-ranked_1000 | CNPY4 BIVM EML5 PTBP3 HDAC6 WNT5A FAT3 CARMIL1 SALL4 VPS36 CLDN7 ROS1 CTNND2 | 2.72e-07 | 227 | 201 | 13 | gudmap_kidney_e10.5_UretericTip_HoxB7_k3_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#4_top-relative-expression-ranked_1000 | EML5 SEL1L3 PKP2 KLHL14 RASGRF2 SALL4 CLDN7 RAB20 ROS1 CTNND2 | 1.11e-05 | 185 | 201 | 10 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k4 |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_k-means-cluster#1_top-relative-expression-ranked_1000 | CNPY4 BIVM EML5 PTBP3 HDAC6 WNT5A CARMIL1 SALL4 VPS36 CLDN7 ROS1 | 1.51e-05 | 234 | 201 | 11 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_k1_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.42e-05 | 124 | 201 | 8 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k3 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CYP26A1 MCAM NDUFA4L2 TAGLN COL6A3 MXRA5 COL12A1 RASGRF2 WNT5A SALL4 | 2.57e-08 | 193 | 207 | 10 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | FRMPD4 MCAM NDST4 NDUFA4L2 NDST3 TAGLN PLP1 COL12A1 WNT5A ZFHX3 | 2.69e-08 | 194 | 207 | 10 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.59e-08 | 200 | 207 | 10 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-07 | 184 | 207 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-07 | 184 | 207 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-07 | 184 | 207 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.17e-07 | 193 | 207 | 9 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.28e-07 | 200 | 207 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.28e-07 | 200 | 207 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-07 | 157 | 207 | 8 | 8d30d8e6fae93afcada6bd68799439335cd65b69 | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-07 | 157 | 207 | 8 | 2ac4695d9e4ca8d4ba19c555e9a1d86ac8f398ab | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-07 | 157 | 207 | 8 | 8a393eece90fb9a1b7c356736bdb36277261fbd3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-06 | 169 | 207 | 8 | 716e9d4c5fb99c56b76afaa5ed90bfa859fde802 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 170 | 207 | 8 | 71c52fadecc6b4bfe98692b266adaa1406f6d56d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-06 | 170 | 207 | 8 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 1.55e-06 | 173 | 207 | 8 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-06 | 181 | 207 | 8 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.55e-06 | 185 | 207 | 8 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 187 | 207 | 8 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 187 | 207 | 8 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 187 | 207 | 8 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.36e-06 | 192 | 207 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.36e-06 | 192 | 207 | 8 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.63e-06 | 194 | 207 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.77e-06 | 195 | 207 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.91e-06 | 196 | 207 | 8 | acbb493dbb49a33f20cf11106363f7ed51209706 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.91e-06 | 196 | 207 | 8 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.91e-06 | 196 | 207 | 8 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-06 | 197 | 207 | 8 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.22e-06 | 198 | 207 | 8 | 89986c7756541df364df516329d10775ba0e78a4 | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.22e-06 | 198 | 207 | 8 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-06 | 198 | 207 | 8 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 4.22e-06 | 198 | 207 | 8 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.38e-06 | 199 | 207 | 8 | 9a08c25bb4851ad4ac9db8916422280f71378c2c | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 4.38e-06 | 199 | 207 | 8 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.54e-06 | 200 | 207 | 8 | 501cd2b4e55444fc5fdd93ebbcfc0616442b110b | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-06 | 151 | 207 | 7 | e243b6c76e59035f10519a86399b598dd2123f87 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-06 | 151 | 207 | 7 | cdd2ce0969da446616627e3569bbe5a5d9b475bd | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 9.74e-06 | 159 | 207 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-05 | 166 | 207 | 7 | 739dfbe927f409821ff23aca6e47ebe78f57e859 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 167 | 207 | 7 | a6ff7a3d9b80839c0efa91658836812e868561fa | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-05 | 168 | 207 | 7 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-05 | 168 | 207 | 7 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-05 | 168 | 207 | 7 | 217770a94ace446cdfc7687b459dece707576e76 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-05 | 169 | 207 | 7 | ccb7b2daa65cb5f4c1e7a48b3bcdf0cb8f7675c3 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 171 | 207 | 7 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 171 | 207 | 7 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-05 | 172 | 207 | 7 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 173 | 207 | 7 | ca3d2a9562734f76127e3e7d54c10b63e95141bb | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-05 | 173 | 207 | 7 | 70c0c13febd28b395fb3171ec8d7fbbc6c9d4eb7 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 173 | 207 | 7 | 19a9e10885173d7712996be8660a3a5a7a9aa39f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.68e-05 | 173 | 207 | 7 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-05 | 116 | 207 | 6 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-05 | 174 | 207 | 7 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-05 | 174 | 207 | 7 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-05 | 175 | 207 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-05 | 175 | 207 | 7 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 176 | 207 | 7 | 6b4afd2c9268172063fe5832896bea15e862579e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-05 | 176 | 207 | 7 | ed421d8525108d2f585265d2cf777f07b29f44f0 | |
| ToppCell | wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.95e-05 | 177 | 207 | 7 | 15a5c96ea840376e54933ebe7a8334a11d9ce411 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.95e-05 | 177 | 207 | 7 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 2.10e-05 | 179 | 207 | 7 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-05 | 180 | 207 | 7 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-05 | 180 | 207 | 7 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.17e-05 | 180 | 207 | 7 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 182 | 207 | 7 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.33e-05 | 182 | 207 | 7 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-05 | 183 | 207 | 7 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-05 | 183 | 207 | 7 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-05 | 183 | 207 | 7 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-05 | 186 | 207 | 7 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.77e-05 | 187 | 207 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.77e-05 | 187 | 207 | 7 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-05 | 187 | 207 | 7 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.87e-05 | 188 | 207 | 7 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-05 | 188 | 207 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-05 | 188 | 207 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-05 | 188 | 207 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.87e-05 | 188 | 207 | 7 | 9fd262bbf6cdebfd945e39428a6059726fb55b3a | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-05 | 188 | 207 | 7 | 502045a39ffb1e92bd9499848368e8fa971edb88 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.87e-05 | 188 | 207 | 7 | 459e3fd4335a6f25f982d011b38702f4fcfed1cd | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.87e-05 | 188 | 207 | 7 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-05 | 189 | 207 | 7 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.97e-05 | 189 | 207 | 7 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 3.18e-05 | 191 | 207 | 7 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 191 | 207 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.28e-05 | 192 | 207 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.28e-05 | 192 | 207 | 7 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.39e-05 | 193 | 207 | 7 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-05 | 193 | 207 | 7 | 88916d9a7d831eb52848599917c04238f8f9812b | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.39e-05 | 193 | 207 | 7 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 3.39e-05 | 193 | 207 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.39e-05 | 193 | 207 | 7 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 3.51e-05 | 194 | 207 | 7 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 3.51e-05 | 194 | 207 | 7 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.51e-05 | 194 | 207 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.51e-05 | 194 | 207 | 7 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-05 | 194 | 207 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.62e-05 | 195 | 207 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | P15-Mesenchymal-myocytic_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.74e-05 | 196 | 207 | 7 | 41ae5b0d81ad09a6663335d899b4a1e4976c3b62 | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; MCF7; HT_HG-U133A | HGF CYP26A1 ACTA1 NDUFA4L2 HEPH NF1 SRGAP3 PKP2 MXRA5 DDX60 LMO7 | 1.93e-06 | 199 | 204 | 11 | 3614_UP |
| Disease | severe acute respiratory syndrome, COVID-19 | FRMPD4 NCAM2 NRXN1 SRGAP3 PRKAG2 COL6A3 MXRA5 SGTB GRK4 DTD2 ZFHX3 CHSY3 | 5.66e-05 | 447 | 199 | 12 | EFO_0000694, MONDO_0100096 |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 1.35e-04 | 3 | 199 | 2 | C0349788 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.56e-04 | 75 | 199 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | Intellectual Disability | FRMPD4 KDM3B NF1 AP1B1 NRXN1 SRGAP3 NDST1 SYNE1 MED13L ZBTB11 HTT | 2.45e-04 | 447 | 199 | 11 | C3714756 |
| Disease | Cardiomyopathies | 2.60e-04 | 130 | 199 | 6 | C0878544 | |
| Disease | Ullrich congenital muscular dystrophy | 2.69e-04 | 4 | 199 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 2.69e-04 | 4 | 199 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 2.69e-04 | 4 | 199 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 2.69e-04 | 4 | 199 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 2.69e-04 | 4 | 199 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 2.69e-04 | 4 | 199 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | Gastrointestinal Stromal Sarcoma | 2.85e-04 | 47 | 199 | 4 | C3179349 | |
| Disease | Gastrointestinal Stromal Tumors | 3.63e-04 | 50 | 199 | 4 | C0238198 | |
| Disease | Ischemic stroke | 3.77e-04 | 324 | 199 | 9 | HP_0002140 | |
| Disease | SYSTEMIC LUPUS ERYTHEMATOSUS 16 | 4.47e-04 | 5 | 199 | 2 | C3280742 | |
| Disease | Squamous cell carcinoma of esophagus | 4.70e-04 | 95 | 199 | 5 | C0279626 | |
| Disease | Brugada Syndrome (disorder) | 5.51e-04 | 24 | 199 | 3 | C1142166 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.98e-04 | 152 | 199 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | axial length measurement, refractive error | 6.67e-04 | 6 | 199 | 2 | EFO_0005318, MONDO_0004892 | |
| Disease | carbamazepine metabolite measurement | 6.67e-04 | 6 | 199 | 2 | EFO_0009891 | |
| Disease | Congenital myopathy with fiber type disproportion | 6.67e-04 | 6 | 199 | 2 | cv:C0546264 | |
| Disease | rhegmatogenous retinal detachment | 6.67e-04 | 6 | 199 | 2 | EFO_0005240 | |
| Disease | azoospermia (implicated_via_orthology) | 7.84e-04 | 27 | 199 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | Malignant mesothelioma | 8.79e-04 | 109 | 199 | 5 | C0345967 | |
| Disease | polycystic liver disease (implicated_via_orthology) | 9.29e-04 | 7 | 199 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | Headache | 9.30e-04 | 64 | 199 | 4 | HP_0002315 | |
| Disease | visual epilepsy (implicated_via_orthology) | 1.55e-03 | 34 | 199 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | glycogen storage disease (is_implicated_in) | 1.58e-03 | 9 | 199 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | gestational age, parental genotype effect measurement | 1.69e-03 | 35 | 199 | 3 | EFO_0005112, EFO_0005939 | |
| Disease | Short Stature, CTCAE | 1.97e-03 | 10 | 199 | 2 | C2919142 | |
| Disease | Short stature | 1.97e-03 | 10 | 199 | 2 | C0349588 | |
| Disease | Kunitz-type protease inhibitor 2 measurement | 1.97e-03 | 10 | 199 | 2 | EFO_0008200 | |
| Disease | Peritoneal Neoplasms | 1.97e-03 | 10 | 199 | 2 | C0031149 | |
| Disease | Carcinomatosis of peritoneal cavity | 1.97e-03 | 10 | 199 | 2 | C0346990 | |
| Disease | diffuse plaque measurement | DCHS2 NCAM2 DNAH14 NDST3 PKP2 HSP90AA4P COL6A3 SHB SALL4 GRIK5 PIERCE1 CHSY3 TNS1 | 2.01e-03 | 758 | 199 | 13 | EFO_0010699 |
| Disease | Congenital long QT syndrome | 2.39e-03 | 11 | 199 | 2 | cv:C1141890 | |
| Disease | interleukin-6 measurement, response to stimulus | 2.39e-03 | 11 | 199 | 2 | EFO_0004810, GO_0050896 | |
| Disease | Profound Mental Retardation | 2.57e-03 | 139 | 199 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.57e-03 | 139 | 199 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.57e-03 | 139 | 199 | 5 | C0917816 | |
| Disease | diabetes mellitus (is_marker_for) | 2.67e-03 | 41 | 199 | 3 | DOID:9351 (is_marker_for) | |
| Disease | hippocampal CA4 volume | 2.67e-03 | 41 | 199 | 3 | EFO_0009396 | |
| Disease | rotator cuff tear, shoulder impingement syndrome | 2.86e-03 | 12 | 199 | 2 | EFO_1001178, EFO_1001250 | |
| Disease | pulmonary function measurement, forced expiratory volume, smoking behaviour measurement | 2.86e-03 | 12 | 199 | 2 | EFO_0003892, EFO_0004314, EFO_0005671 | |
| Disease | Long QT syndrome | 2.86e-03 | 12 | 199 | 2 | cv:C0023976 | |
| Disease | hemorrhoid | 3.27e-03 | 147 | 199 | 5 | EFO_0009552 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 3.36e-03 | 13 | 199 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 3.36e-03 | 13 | 199 | 2 | C0175709 | |
| Disease | kynurenic acid measurement | 3.36e-03 | 13 | 199 | 2 | EFO_0010506 | |
| Disease | X-linked centronuclear myopathy | 3.36e-03 | 13 | 199 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 3.36e-03 | 13 | 199 | 2 | C4551952 | |
| Disease | Brugada Syndrome 1 | 3.36e-03 | 13 | 199 | 2 | C4551804 | |
| Disease | response to ketamine, dissociation measurement | 3.36e-03 | 13 | 199 | 2 | EFO_0009748, EFO_0009750 | |
| Disease | Congenital Structural Myopathy | 3.36e-03 | 13 | 199 | 2 | C0752282 | |
| Disease | urate measurement, bone density | LINC00587 DNAH14 TPRG1 TTC28 PPFIBP1 SYNE1 SGTA CARMIL1 HSD17B12 CTNNA1 CTNND2 | 3.36e-03 | 619 | 199 | 11 | EFO_0003923, EFO_0004531 |
| Disease | obesity (implicated_via_orthology) | 3.49e-03 | 215 | 199 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | eye morphology measurement | 3.73e-03 | 218 | 199 | 6 | EFO_0007858 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 3.90e-03 | 14 | 199 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 3.90e-03 | 14 | 199 | 2 | C0410207 | |
| Disease | Left ventricular noncompaction | 3.90e-03 | 14 | 199 | 2 | C1960469 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 3.90e-03 | 14 | 199 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | Cardiomyopathy | 3.94e-03 | 47 | 199 | 3 | cv:C0878544 | |
| Disease | Cardiomyopathy, Dilated | 4.18e-03 | 48 | 199 | 3 | C0007193 | |
| Disease | hippocampal CA1 volume | 4.18e-03 | 48 | 199 | 3 | EFO_0009394 | |
| Disease | unipolar depression, bipolar disorder | 4.21e-03 | 156 | 199 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | hepatoblastoma (is_marker_for) | 4.49e-03 | 15 | 199 | 2 | DOID:687 (is_marker_for) | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 4.49e-03 | 15 | 199 | 2 | C3645536 | |
| Disease | anemia (implicated_via_orthology) | 4.49e-03 | 15 | 199 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Tourette syndrome | 4.69e-03 | 50 | 199 | 3 | EFO_0004895 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 4.73e-03 | 229 | 199 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | lymphocyte count | FMNL2 ADCY5 ABCG4 KLHL14 RANBP10 ABCC1 MMS22L TTC28 PCDHGB5 RBL1 GRIK5 MED13L CLSTN1 SBNO2 ZNF710 PDLIM4 PAPPA ACAP2 HTT | 4.95e-03 | 1464 | 199 | 19 | EFO_0004587 |
| Disease | Barrett Epithelium | 5.10e-03 | 16 | 199 | 2 | C1258085 | |
| Disease | Romano-Ward Syndrome | 5.10e-03 | 16 | 199 | 2 | C0035828 | |
| Disease | sickle cell anemia (is_implicated_in) | 5.10e-03 | 16 | 199 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | Barrett Esophagus | 5.10e-03 | 16 | 199 | 2 | C0004763 | |
| Disease | chronic kidney disease | 5.36e-03 | 235 | 199 | 6 | EFO_0003884 | |
| Disease | response to cisplatin, platinum measurement | 5.52e-03 | 53 | 199 | 3 | EFO_0010154, GO_0072718 | |
| Disease | apolipoprotein B measurement | DCHS2 CYP26A1 NF1 PMPCA FGB NKPD1 TAGLN APOB CSNK1G3 ZFHX3 HTT | 5.59e-03 | 663 | 199 | 11 | EFO_0004615 |
| Disease | Glycogen storage disease | 5.76e-03 | 17 | 199 | 2 | cv:C0017919 | |
| Disease | muscular dystrophy (is_implicated_in) | 5.76e-03 | 17 | 199 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Moyamoya Disease | 5.76e-03 | 17 | 199 | 2 | C0026654 | |
| Disease | body fat percentage | 6.12e-03 | 488 | 199 | 9 | EFO_0007800 | |
| Disease | Premature atrial contractions | 6.13e-03 | 55 | 199 | 3 | HP_0006699 | |
| Disease | pulse pressure measurement | ADCY5 ITIH3 PKD1 PRKAG2 COL6A3 MXRA5 TTC28 FAT3 CARMIL1 SHB CELA2B INO80 MED13L SLC5A11 FMNL3 CSNK1G3 ZFHX3 CTNND2 | 6.41e-03 | 1392 | 199 | 18 | EFO_0005763 |
| Disease | Congenital Fiber Type Disproportion | 6.45e-03 | 18 | 199 | 2 | C0546264 | |
| Disease | Leukemia, Myelocytic, Acute | 6.49e-03 | 173 | 199 | 5 | C0023467 | |
| Disease | Alzheimer disease, polygenic risk score | DNAJA2 PICALM DNAH14 NRXN1 SLC4A9 CSTPP1 MMS22L NCKIPSD CHSY3 CTNNA1 | 6.70e-03 | 586 | 199 | 10 | EFO_0030082, MONDO_0004975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HELGLAFTKNRMNYT | 121 | O95150 | |
| QRKGESDGAYIHRMQ | 116 | Q6PK04 | |
| LMDKHLAGYFNNTRI | 16 | Q5RHP9 | |
| AGKSTFMNILAGYRE | 106 | Q9H172 | |
| MKQNLDELGIGTYHN | 421 | Q9UGJ0 | |
| LNRMEYRLQKGAGFH | 741 | Q96Q91 | |
| RHKGEMENALRSYSN | 466 | Q99996 | |
| RKGSLRYAKGQSQTM | 106 | Q8N129 | |
| IMKKRNGGGSLNNYS | 246 | Q5VTM2 | |
| KGYMRIQQFRKADGS | 1051 | P0C0L5 | |
| IRKDLYANNVMSGGT | 291 | P68133 | |
| YRTGQHSNKFMLVLA | 486 | Q9NVI7 | |
| GKGRLDYHMSQNEKR | 4211 | Q6V0I7 | |
| NEMHVGSLLNGRKYS | 1286 | Q68CP9 | |
| KMSSIHERRNSGYQG | 481 | Q86UB2 | |
| ANSMRLKYQHTGAVL | 46 | O43684 | |
| ADGYKHMSLALNRTG | 181 | P06280 | |
| EGQDMLYQSLKLTNG | 891 | Q10567 | |
| GELDKAMQHISYLNS | 596 | O94985 | |
| GIVMEGYLFKRASNA | 266 | Q15057 | |
| YNHLGGNQVSKEMKR | 681 | O95622 | |
| DVDGSGNYLMLTHKQ | 631 | Q7L7V1 | |
| TMHLGLKSTGNYVDF | 1186 | Q9UQB3 | |
| DTLFGEMLHGYNNRT | 771 | O75129 | |
| GFSLHYQKARGMDNV | 461 | Q8TDY8 | |
| IFMTHLSNYGNDRLG | 516 | O95803 | |
| GREYGKNLAHTEMLQ | 526 | Q6VN20 | |
| LGDMNVGKTSLLQRY | 11 | Q9NX57 | |
| SMRDLYIKNGQGFIL | 66 | P10114 | |
| GFRNYNTSIDMQRGK | 706 | Q6ZMN7 | |
| SMRDLYIKNGQGFIL | 66 | P61225 | |
| SMRDLYIKNGQGFIL | 66 | Q9Y3L5 | |
| GMLNTYSLNGVLQSE | 91 | Q9ULG1 | |
| SINSGNGKLYALRTM | 506 | Q9Y5F3 | |
| VNSPHRQYKGMFDTL | 156 | Q9H2D1 | |
| IRFLKGMGYSTHAAQ | 436 | Q9Y5A7 | |
| QSVYLMNLRKSGTLG | 71 | Q16595 | |
| NLQYGEDMRHPGSRK | 13021 | Q8WXI7 | |
| FLTKNNLKYMARGGL | 131 | Q504Q3 | |
| GGMFRNNTLNVYLEK | 91 | Q5BN46 | |
| NRGNAGVKRSAAEMY | 91 | O60812 | |
| GGRLKGRNMQYHSNS | 96 | Q96FN9 | |
| QGYRLDKEGNSMSRH | 56 | P59901 | |
| TLSYGMFENKRNAVH | 331 | Q8NES3 | |
| AIMNRKLGYNSGLFL | 1166 | Q71F56 | |
| RNGYRALMDKSLHVG | 51 | Q16655 | |
| NRGNAGVKRSAAEMY | 91 | B2RXH8 | |
| SLMNKEESYGGRDQH | 156 | A6NFK2 | |
| YTLQKGQRRAGMATE | 391 | O75648 | |
| NGGDLMYHIQDKGRF | 431 | Q05655 | |
| LMEQGLGSYLNSGKH | 656 | Q86W92 | |
| EIGHLTGLQKFYMAS | 206 | A6NIV6 | |
| GLGNRVSVMSYSAKF | 186 | P13716 | |
| QREAYSKLLSHLGQM | 1216 | Q6ZRQ5 | |
| FNTTMGKLQRQLYKG | 21 | Q8IYT1 | |
| NRGNAGVKRSAAEMY | 91 | B7ZW38 | |
| SILAALRKMQDGYFG | 581 | P46020 | |
| AHMLLNKTFGSYLGV | 56 | A6NL99 | |
| IMFNYLDQKLGGSSG | 386 | O95786 | |
| YKHGSLIGLVQDNRM | 1646 | Q8IY21 | |
| QFGGMLLAYSGVQSK | 326 | Q9BPX6 | |
| SVNKYRGTAGNALMD | 371 | P02675 | |
| YQLKIRGSNMAGAFT | 1726 | Q9NYQ8 | |
| NVGMSTLYDIRAHKA | 46 | O75564 | |
| HSTLQMDGAQRGLAY | 26 | O60928 | |
| FMTHLSNYGNDRLGL | 526 | P52848 | |
| GTALYNIGDMVHAAR | 1101 | Q7LBC6 | |
| AYMESQGAHRAGLAK | 36 | Q6B0I6 | |
| RLFQKIYGENGSKSM | 691 | Q8WWI1 | |
| RMDGSYRSVELKHGN | 426 | O00522 | |
| RGSGYQGDKIMHAIN | 581 | P27487 | |
| AGKGYSHDNRTAQIM | 571 | A0A1B0GV03 | |
| AMVGGLFRNIKYNLD | 71 | Q13630 | |
| NRGNAGVKRSAAEMY | 91 | P0DMR1 | |
| GKNYMGNLSQTRSGL | 396 | P14210 | |
| FMTHLSNYGNDRLGL | 516 | Q9H3R1 | |
| QRNGLMLHTGKSADY | 316 | Q9ULB1 | |
| DLGLNGQVSYSIMAS | 476 | Q9Y5G0 | |
| KVLMLGGSALNHNYR | 236 | Q13219 | |
| MNNYFGIGLDAKISL | 771 | Q86XP1 | |
| GTARYMSINTHLGKE | 211 | Q9Y6M4 | |
| TEFNGIRDYHKRGSM | 211 | Q9NUU6 | |
| AKNLYRVGFEGMSDL | 201 | Q86YT6 | |
| IDMDSGKNGQLLYFL | 1216 | Q6V1P9 | |
| MAGASLGARFYRQIK | 1 | Q9NRX3 | |
| GGFYSNRSLALVMSQ | 191 | Q8N414 | |
| QRDGNDLHMTYKIGL | 261 | O60884 | |
| GYLSDRAMAKAGLSN | 281 | O43826 | |
| GSAYQAMILGVDSKN | 1711 | P04114 | |
| ELGSMSYKLGQVSIH | 2606 | P42858 | |
| MNDRLYAIGGNHLKG | 516 | Q9P2G3 | |
| FKLAVDNMQYLGEGT | 861 | Q2UY09 | |
| YMGNAGRKERSDALN | 351 | P35221 | |
| YGFLMALSKHRGINQ | 236 | Q9H6J7 | |
| SSSGIYRVMLGQHNL | 76 | P08218 | |
| YKGGNTLTGMALNFI | 1271 | Q99715 | |
| MAASGLDHLKNGYRR | 1 | Q03188 | |
| RKDMSGHYQNALYLG | 726 | P53621 | |
| RNLYIGSANDMKGLD | 686 | Q14CM0 | |
| LALGNYMNSSKRGAV | 771 | Q8IVF7 | |
| NQTGKGLEYIMQSHL | 116 | P12111 | |
| GLEYIMQSHLTKAAG | 121 | P12111 | |
| LIYTIEAGNTGNMFK | 1601 | Q8TDW7 | |
| NGFYMRADQSGTLLA | 471 | Q9NQT6 | |
| QSRTNGYLIHALMGS | 266 | Q53GQ0 | |
| LALGNYMNSSKRGAV | 826 | Q96PY5 | |
| IIGNSMGLVNAYSHK | 671 | Q0VDD8 | |
| SLLGFVYKLEGNMNE | 441 | P09914 | |
| FNTSMGKLQRQLYKG | 21 | Q8NEG0 | |
| HYDMIERKLGSRNSN | 381 | Q17RS7 | |
| GNVLRGDDLSHMYNF | 346 | Q5VZK9 | |
| SGLYRGMKARNLIHA | 231 | O43174 | |
| LQTNDGNGKRLFYRM | 466 | Q05BV3 | |
| KYCGLGLQMNHSIES | 146 | Q96PD2 | |
| THANRIYRMNKLGLG | 371 | Q58FG1 | |
| ILNAYGMGDRKRTNS | 16 | B1AMM8 | |
| LMQGSRGLTDQAIFY | 1091 | Q9UBN7 | |
| LGGSMNSVSKLIHYV | 526 | Q92674 | |
| REMRLSNGKLYSAGA | 881 | Q16478 | |
| IMNGGDLKFHIYNLG | 266 | P32298 | |
| GGLESRVLKYTAQNM | 176 | O43889 | |
| QYTSMLNGGLAVKTN | 971 | Q9UJQ4 | |
| LLKFLQMNGYAVTRG | 2926 | P21817 | |
| IYFLGLNAKKRQGMT | 181 | Q92630 | |
| KGYMRIQQFRKADGS | 1051 | P0C0L4 | |
| LKMSSGQEYLFRHGD | 366 | Q9UNU6 | |
| GTYHVQLRATNMLGS | 1691 | P98161 | |
| LVNMNGYTKGARNEL | 636 | O15294 | |
| NYRLPSGNHMKESRE | 226 | P43121 | |
| QQRGLFYSMAKDAGL | 1516 | P33527 | |
| HMYQARGLIAADSNG | 831 | Q2WGJ9 | |
| GFNLYDHLSNMLTKI | 226 | Q5TD94 | |
| GKGMFSRLYLNVLNR | 356 | Q10713 | |
| GKGFEDLMTVNLARY | 76 | Q7RTN6 | |
| GSFLEDARAYMKGQL | 371 | Q9HA77 | |
| RLSSMNLGYKHYQGI | 606 | Q68CR1 | |
| KHDYSLSLRSNQGFM | 441 | Q15464 | |
| SYVGRGLNSDQLSML | 506 | P52630 | |
| FYSGGMINNAIASLR | 41 | A6NJY1 | |
| AYGRMGLALSSLNKH | 161 | O43765 | |
| KMYHSLAGSLQDSGI | 4816 | Q8NF91 | |
| MGRTLANKHGYDVDS | 351 | Q7LBE3 | |
| MKGTADNGYLFLNRT | 286 | Q17RQ9 | |
| GNFRMIGDDLVNSYH | 186 | P28749 | |
| MQKSVRYNEGHALYL | 1 | O14827 | |
| LNATNYFGRIVDKHM | 891 | Q587J7 | |
| RKTYFGKLGIANAQM | 706 | Q06033 | |
| FSEYHEKRMLVSGQG | 126 | Q9BXW7 | |
| AINGKLYANLRGLTM | 966 | Q9BQS7 | |
| KQSGSFRYLQGMLEA | 206 | P50479 | |
| NYATLKGHSGAVMEL | 101 | Q96DI7 | |
| HPDLFQNRMLSKSGY | 401 | P13521 | |
| VGMQLFGKNYSELRD | 856 | Q14524 | |
| NLSHAKGGALMAAYL | 301 | Q8WWX8 | |
| KVSGMYIARQLSFSG | 471 | Q9Y2G9 | |
| MALGSLAVTKNDGHY | 131 | Q01995 | |
| NTAMRDGGKYSLEQR | 76 | Q9NZQ3 | |
| ERMGVTYGAQAHLKS | 891 | Q9UL12 | |
| MKLSVNEAQLGFYLG | 1 | Q8IY92 | |
| LNFYKQTMDLLTGSG | 151 | Q7Z7C7 | |
| AGDNIITAQAMYKGL | 36 | O95471 | |
| GVMTAQKYLGSRALA | 176 | Q70JA7 | |
| LSNFLDKSGLQGYDM | 106 | Q13492 | |
| GIMNLNGRDYIFSKA | 356 | P52655 | |
| SSILSMYQAARAGGQ | 221 | Q96HA9 | |
| FNMNIRGDIGHKAYE | 121 | Q8IYI8 | |
| ISANGSNLYDAVRMG | 966 | P82094 | |
| AMAYGSSLAAQGKEL | 81 | Q5BJH7 | |
| AKRHNLAIDLMYGGI | 96 | Q9UPT9 | |
| SVNEGAYIRLHKGME | 511 | O95625 | |
| STKLVSGFLMGQRYH | 271 | Q8TAW3 | |
| QREIMGLTKHGLEYS | 101 | Q8NA42 | |
| GNKDSIYSLAMNQLG | 166 | Q8TAF3 | |
| GSGTQYHMQLAKQLA | 236 | Q86VN1 | |
| EAASRIGGHQKSMYL | 381 | O15394 | |
| KRRMATFGSAGSINY | 911 | O43295 | |
| MEDFLLSNGYQLGKT | 1 | Q96PN8 | |
| AVSLQGKLYMANAGD | 221 | Q96MI6 | |
| GKLYMANAGDSRAIL | 226 | Q96MI6 | |
| LVNQHSILMGEGSYK | 166 | Q96K75 | |
| VHYFSGLLSGSIKMN | 166 | Q9HBL0 | |
| LGATLLKMGIQHAYS | 316 | P05543 | |
| YTGLMSFIGNRNKLG | 251 | Q6ZUI0 | |
| TMAAFGLKYLLNDTG | 106 | Q9GZP7 | |
| VCGKSFNRMYNLLGH | 551 | Q8N1W2 | |
| DYSSNILSLGKMNGL | 1221 | Q6P2S7 | |
| GLGYHKDLQTRATFM | 1166 | P21359 | |
| RHLYFALKESQNGMQ | 1236 | P08922 | |
| HAKGSYESARILMNL | 206 | P41221 | |
| GYTHMKIAEGVNSLL | 321 | P35250 | |
| HLLSSGKFMYLEGNA | 421 | O14763 | |
| YEHNNRKMSGLIVGS | 321 | Q9UKN8 | |
| GTYMATSGLDHQLKI | 371 | O15213 | |
| AMNHLSGQRLYGKVL | 411 | O95758 | |
| GYLLSGFTVAMDNLK | 451 | Q9UJA5 | |
| ASSNLGIIHQMKGDY | 476 | Q96AY4 | |
| IANDLFYKGALMNGV | 1886 | Q86YA3 | |
| FNMNIRGDIGHKAYE | 141 | Q9UC07 | |
| YGRMGLALTALNKFE | 156 | Q96EQ0 | |
| NMTFSNGKLRVKGIY | 41 | Q6UY13 | |
| GAHMNVGRTYKNLNR | 481 | Q6ZXV5 | |
| RQGQSSHYGQMDRKG | 336 | Q6XPR3 | |
| SSIKNAYEGMLAHQR | 96 | Q2TAA8 | |
| FNMNIRGDIGHKAYE | 121 | Q0D2J5 | |
| MASAGTQHYSIGLRQ | 1 | Q14679 | |
| SMGNLLEKENYLTAG | 251 | Q99959 | |
| HEAKRAGYNLTLSAM | 2736 | Q15911 | |
| MKDIGQQLYTTHLNG | 1 | Q9C0D4 | |
| GQRHMDLLTGYSKLI | 16 | Q9UFV3 | |
| HGGKMFVYLENGQSL | 291 | Q86TJ5 | |
| LYNLGGSRSISINLM | 61 | Q7Z794 | |
| SGQQLQRFYHKADGM | 2586 | Q9NR99 | |
| ATYNFAVLKLMGRGT | 261 | P60201 |